Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Overcoming Taxane Resistance: Preclinical and Phase 1 Studies of Relacorilant, a Selective Glucocorticoid Receptor Modulator, with Nab-Paclitaxel in Solid Tumors.
Clin Cancer Res. 2022 Aug 2;28(15):3214-3224. doi: 10.1158/1078-0432.CCR-21-4363.
Clin Cancer Res. 2022.
PMID: 35583817
Free PMC article.
Clinical Trial.
Relacorilant + Nab-Paclitaxel in Patients With Recurrent, Platinum-Resistant Ovarian Cancer: A Three-Arm, Randomized, Controlled, Open-Label Phase II Study.
Colombo N, Van Gorp T, Matulonis UA, Oaknin A, Grisham RN, Fleming GF, Olawaiye AB, Nguyen DD, Greenstein AE, Custodio JM, Pashova HI, Tudor IC, Lorusso D.
Colombo N, et al. Among authors: pashova hi.
J Clin Oncol. 2023 Oct 20;41(30):4779-4789. doi: 10.1200/JCO.22.02624. Epub 2023 Jun 26.
J Clin Oncol. 2023.
PMID: 37364223
Free PMC article.
Clinical Trial.
Item in Clipboard
Association between caries location and restorative material treatment provided.
Lubisich EB, Hilton TJ, Ferracane JL, Pashova HI, Burton B; Northwest PRECEDENT.
Lubisich EB, et al. Among authors: pashova hi.
J Dent. 2011 Apr;39(4):302-8. doi: 10.1016/j.jdent.2011.01.007. Epub 2011 Jan 21.
J Dent. 2011.
PMID: 21256915
Free PMC article.
Item in Clipboard
Cite
Cite